These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 7568369)

  • 1. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Biol Psychiatry; 1995 Sep; 38(5):325-9. PubMed ID: 7495927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function.
    Cameron OG; Abelson JL; Young EA
    Biol Psychiatry; 2004 Dec; 56(11):875-83. PubMed ID: 15576065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four hour growth hormone secretion in patients with panic disorder.
    Abelson JL; Curtis GC; Uhde TW
    Psychoneuroendocrinology; 2005 Jan; 30(1):72-9. PubMed ID: 15358444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD; Papp LA; Martinez J; Pine D; Rosenblum LA; Cooper T; Liebowitz MR; Gorman JM
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity of depression and panic disorder.
    Gorman JM; Coplan JD
    J Clin Psychiatry; 1996; 57 Suppl 10():34-41; discussion 42-3. PubMed ID: 8917130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of GHRH stimulation test in psychiatry.
    Skare SS; Dysken MW; Billington CJ
    Biol Psychiatry; 1994 Aug; 36(4):249-65. PubMed ID: 7986890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological aspects of depression.
    Matussek N
    Psychopathology; 1986; 19 Suppl 2():66-71. PubMed ID: 3033728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.